{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:09:20Z","timestamp":1778602160480,"version":"3.51.4"},"reference-count":12,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"unspecified","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MyAware","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004789","name":"John Fell Fund, University of Oxford","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X022013\/1"],"award-info":[{"award-number":["MR\/X022013\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,3,1]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Chorea-acanthocytosis (ChAc) is a rare genetic disorder characterised by a hyperkinetic movement disorder, dystonia, cognitive and neuropsychiatric deficits and seizures.<\/jats:p>\n                  <jats:p>\n                    We report the case of a 30-year-old patient who presented with a decade of episodic neurological dysfunction and seizures. The condition was initially suspected to be an immunotherapy-responsive seronegative autoimmune encephalitis but progressed to oromandibular dystonia, raising suspicion of a neurodegenerative condition. Neuroimaging showed bilateral caudate atrophy and acanthocytes were seen on blood film microscopy in association with raised creatine kinase. Genetic testing revealed our patient to be compound heterozygous for two pathogenic variants in the\n                    <jats:italic>VPS13A<\/jats:italic>\n                    gene and confirmed the diagnosis of ChAc.\n                  <\/jats:p>\n                  <jats:p>This case highlights the importance of considering ChAc in the differential diagnosis of a progressive treatment-refractory seizure disorder in the context of oromandibular dystonia.<\/jats:p>","DOI":"10.1136\/bmjno-2025-001531","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:25:12Z","timestamp":1774369512000},"page":"e001531","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Chorea-acanthocytosis masquerading as a progressive seizure disorder with apparent early immunotherapy responsiveness"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1108-9306","authenticated-orcid":false,"given":"Amarachi","family":"Nwamba","sequence":"first","affiliation":[{"name":"University of Oxford Medical Sciences Division, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beheshta","family":"Harghandiwal","sequence":"additional","affiliation":[{"name":"University of Oxford Medical Sciences Division, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Ceronie","sequence":"additional","affiliation":[{"name":"University of Oxford Nuffield Department of Clinical Neurosciences, Oxford, UK"},{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Needham","sequence":"additional","affiliation":[{"name":"University of Cambridge Department of Clinical Neurosciences, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hutchinson","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cleaver","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, UK"},{"name":"University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-6346","authenticated-orcid":false,"given":"Adam","family":"Handel","sequence":"additional","affiliation":[{"name":"University of Oxford Nuffield Department of Clinical Neurosciences, Oxford, UK"},{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026051208153328000_8.1.e001531.1","unstructured":"Peikert K , Dobson-Stone C , Rampoldi L , et al . VPS13A disease. In: GeneReviews. 2023."},{"key":"2026051208153328000_8.1.e001531.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06045-0"},{"key":"2026051208153328000_8.1.e001531.3","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.31206"},{"key":"2026051208153328000_8.1.e001531.4","unstructured":"Johns Hopkins University BMDWWWU . Online mendelian inheritance in man, OMIM. 2026. Available: https:\/\/omim. org"},{"key":"2026051208153328000_8.1.e001531.5","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-6-68","article-title":"Neuroacanthocytosis syndromes","volume":"6","author":"Jung","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"2026051208153328000_8.1.e001531.6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/epi4.13019","article-title":"The use of steroids in adult epilepsy: A systematic review","volume":"10","author":"Walsh","year":"2025","journal-title":"Epilepsia Open"},{"key":"2026051208153328000_8.1.e001531.7","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01181-y","article-title":"Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis","volume":"9","author":"Peikert","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2026051208153328000_8.1.e001531.8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22863"},{"key":"2026051208153328000_8.1.e001531.9","doi-asserted-by":"publisher","DOI":"10.1097\/01.wco.0000173464.01888.e9"},{"key":"2026051208153328000_8.1.e001531.10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mdc3.13269","article-title":"The Spectrum of Movement Disorders in Neuroacanthocytosis Syndromes: A Video Series","volume":"8","author":"Neeraja","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"2026051208153328000_8.1.e001531.11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/epi.13318","article-title":"Seizures as presenting and prominent symptom in chorea-acanthocytosis with c.2343del VPS13A gene mutation","volume":"57","author":"Benninger","year":"2016","journal-title":"Epilepsia"},{"key":"2026051208153328000_8.1.e001531.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00005-2"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:16:47Z","timestamp":1778599007000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,24]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjno-2025-001531"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001531","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}